Cynthia LaCivita, PharmD

Director Division of RIsk Managment
US Food and Drug Administration
Silver Spring, United States

Disclosure information not submitted.

Presentation(s):

• The Teratogenic Risk Impact and Mitigation (TRIM) Tool: Development of explicit criteria for teratogenicity risk mitigation programs

  Monday, August 26, 2024
  1:45 PM – 2:00 PM CEST

• Risk of Prenatal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool

  Monday, August 26, 2024
  2:00 PM – 2:15 PM CEST

• The Teratogenic Risk Impact and Mitigation (TRIM) Tool: Development of Scoring Weights to Prioritize Medications for Risk Management Beyond Labelling

  Monday, August 26, 2024
  2:15 PM – 2:30 PM CEST

• Impact of Risk Evaluation and Mitigation Strategies on Teratogenic Medications Among Publicly and Privately Insured Reproductive-Age Women

  Monday, August 26, 2024
  2:45 PM – 3:00 PM CEST